ExAblate Receives Approval of Health Canada for the Treatment of Uterine Fibroids and Pain Palliation of Bone Metastases

InSightec Ltd, a leader in MR guided Focused Ultrasound therapy, announced that its ExAblate system has received approval of Health Canada for MRgFUS treatment of uterine fibroids and for pain palliation of bone metastases.

ExAblate Receives Approval of Health Canada for the Treatment of Uterine Fibroids and Pain Palliation of Bone Metastases (via PR Newswire)

Third generation ExAblate system, using non-invasive MR guided Focused Ultrasound (MRgFUS) now available for Canadian patients TIRAT CARMEL, Israel, August 22, 2013 /PRNewswire/ — InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced…

published: August 22, 2013 in: Approval/Clearance, Gynaecology/Obstetrics

Most read

Latest

^